Your browser doesn't support javascript.
Discovering drugs to treat coronavirus disease 2019 (COVID-19).
Dong, Liying; Hu, Shasha; Gao, Jianjun.
  • Dong L; Department of Pharmacology, School of Pharmacy, Qingdao University, Qingdao, Shandong, China.
  • Hu S; Department of Pathology, the Affiliated Hospital of Qingdao University, Qingdao, Shandong, China.
  • Gao J; Department of Pharmacology, School of Pharmacy, Qingdao University, Qingdao, Shandong, China.
Drug Discov Ther ; 14(1): 58-60, 2020.
Article in English | MEDLINE | ID: covidwho-5186
ABSTRACT
The SARS-CoV-2 virus emerged in December 2019 and then spread rapidly worldwide, particularly to China, Japan, and South Korea. Scientists are endeavoring to find antivirals specific to the virus. Several drugs such as chloroquine, arbidol, remdesivir, and favipiravir are currently undergoing clinical studies to test their efficacy and safety in the treatment of coronavirus disease 2019 (COVID-19) in China; some promising results have been achieved thus far. This article summarizes agents with potential efficacy against SARS-CoV-2.
Subject(s)
Keywords
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Antiviral Agents / Coronavirus Infections / Drug Discovery / Betacoronavirus Type of study: Prognostic study Limits: Humans Language: English Journal: Drug Discov Ther Year: 2020 Document Type: Article Affiliation country: Ddt.2020.01012

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Antiviral Agents / Coronavirus Infections / Drug Discovery / Betacoronavirus Type of study: Prognostic study Limits: Humans Language: English Journal: Drug Discov Ther Year: 2020 Document Type: Article Affiliation country: Ddt.2020.01012